Epoetin alfa improves survival after chemoradiation for Stage III esophageal cancer: Final results of a prospective observational study

Dirk Rades^*, Silke Tribius, Emre F. Yekebas, Roia Bahrehmand, Ingeborg Wildfang, Ergin Kilic, Ulrich Muellerleile, Eberhard Gross, Steven E. Schild, Winfried Alberti

^*Corresponding author for this work